Stuart Loesch

As a member of the Executive Leadership Team, Mr. Loesch is responsible for commercialization of Intrommune’s future therapeutics. He oversees sales, marketing, market access and commercial operations for the company.

Mr. Loesch joined Intrommune Therapeutics in August 2021 with nearly 30 years of commercial leadership experience in the pharmaceutical industry, with a particular focus in the allergy, asthma and COPD therapeutic areas. Previously, as Vice President of Marketing and Commercial Strategy for ALK-Abelló, he was instrumental in building out the commercial organization in support of several product launches and line extensions across the U.S. and Canada. At Meda Pharmaceuticals, Mr. Loesch served as Senior Vice President of Sales and Marketing where he was responsible for leading the commercialization of more than 30 products, including 4 products directly promoted by the company’s sales force. He was also responsible for leading the divestiture activities for the company’s U.S. Business. His prior experience includes serving in global and executive leadership, marketing and sales roles at Glaxo Smith Kline, Altana, Nycomed, Schering-Plough, Merck and Teva Respiratory.

As a graduate of THE Ohio State University, Mr. Loesch holds a B.S. in Biomedical Communications with a minor in Biology.